Cholangitis: Clinical Trials

6 trials for Cholangitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Unknown 6

Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy
Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy, Placebo of Bezafibrate in addition to standard UDCA therapy - Primary Sclerosing Cholangitis, Cholestasis
Phase 3UnknownAssistance Publique - Hôpitaux de Paris1042021-04-062022-05-10
Kaffes Stent in the Management of Post-surgical Biliary Strictures
Metallic stent, Multiple plastic stents - Benign Biliary Stricture, Biliary Stricture
Phase 3UnknownCairo University302018-07-012020-03-17
norUrsodeoxycholic Acid vs Placebo in PSC
norUrsodeoxycholic Acid - Primary Sclerosing Cholangitis
Phase 3UnknownDr. Falk Pharma GmbH3032018-02-082024-08-06
The Effect of Bezafibrate on Cholestatic Itch
Bezafibrate, Placebo - Primary Biliary Cholangitis, Primary Sclerosing Cholangitis
Phase 3UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)842016-02-012016-03-08
Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis
plastic endoprosthesis, balloon dilatation - Primary Sclerosing Cholangitis
Phase 3UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1002011-05-012012-07-09
Probiotics in Patients With Primary Sclerosing Cholangitis
Probiotics - Primary Sclerosing Cholangitis
Phase 3UnknownUMC Utrecht122005-01-012007-01-09

Narrower conditions

Cholangitis, Sclerosing (5)  ·  Cholestasis (2)  ·  Pruritus (2)  ·  Liver Cirrhosis, Biliary (1)

Broader conditions

Bile Duct Diseases (6)  ·  Biliary Tract Diseases (6)  ·  Digestive System Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Skin Diseases (2)  ·  Skin Manifestations (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Cholestasis, Intrahepatic (1)  ·  Fibrosis (1)  ·  Liver Cirrhosis (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)

Interventions

Bezafibrate (2)  ·  24-norursodeoxycholic acid (1)  ·  Probiotics (1)  ·  Self Expandable Metallic Stents (1)

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cairo University (1)  ·  Dr. Falk Pharma GmbH (1)  ·  UMC Utrecht (1)

Countries

Netherlands (3)  ·  Austria (1)  ·  Belgium (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  Norway (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Cyriel Y Ponsioen, dr. (1)  ·  Michael Trauner, MD (1)

Results publications

PMID 28535810, PMID 29803836, PMID 33031833, PMID 38977324